首页> 外文期刊>European Journal of Pharmacology: An International Journal >The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats.
【24h】

The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats.

机译:选择性sigma(1)受体激动剂1-(3,4-二甲氧基苯乙基)-4-(苯丙基)哌嗪(SA4503)阻止大鼠中对(-)-烟碱的条件化位置偏好响应的获得。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We examined the effect of the sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), on the acquisition of the conditioned place preference response to subcutaneously administered (-)-nicotine in rats. (-)-Nicotine, but not SA4503 or vehicle, produced a significant conditioned place preference response. Pretreatment of animals with either 1 or 3 mg/kg of SA4503 significantly attenuated the conditioned place preference response to (-)-nicotine.
机译:我们研究了sigma(1)受体激动剂1-(3,4-二甲氧基苯乙基)-4-(苯丙基)哌嗪(SA4503)对获得皮下给药(-)-尼古丁的条件性位置偏爱反应的影响在大鼠中。 (-)-尼古丁而不是SA4503或媒介产生显着的条件性位置偏爱响应。用1或3 mg / kg的SA4503预处理动物可显着减弱对(-)-烟碱的条件化位置偏好响应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号